Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.As of 25 Jun 2026, SAI LIFE SCIENCES LIMITED share price is ₹1,205.00. The stock opened at ₹1,226.00, compared to its previous close of ₹1,217.60. During today's trading session, SAI LIFE SCIENCES LIMITED share price moved in the range of ₹1,201.00 to ₹1,229.30, with an average price of ₹1,215.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,201.00 and a high of ₹1,229.30. On the performance front, SAI LIFE SCIENCES LIMITED share price has increased by 33.78% over the last six months and is up 61.33% on a year-on-year basis.
The market capitalization of SAI LIFE SCIENCES LIMITED is ₹25,814 Crs, with a P/E ratio of 74.0 and a dividend yield of 0.00%.